OGN News and Press, Organon & Co. From 09/01/21

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Citi’s 16th Annual BioPharma Virtual Conference on Friday, September 10, 2021 at 9:45 a.m. EDT. Investo...

Merck continues to attract me for a long-term investment. The company has seen an eventful year, notably with the spinoff of Organon. Pro forma multiples have risen a bit following the spinoff as growth outside Keytruda would be very much welcome here. Despite non-Keytruda gro...

The S&P 500 is potentially on track for the greatest year in market history and is 30% historically overvalued. But for those with the right watchlists and tools, Buffett-style "fat pitch" deals are always available. Today Amazon, Bristol Myers, Organon, and BorgWarner represe...

Berkshire Hathaway's 13F stock portfolio value increased from $270.44B to $293.02B this quarter. Their largest three holdings are at ~64% of the entire portfolio. Berkshire Hathaway increased Kroger while reducing Merck and Liberty Global during the quarter. For further deta...

On its Q2 earnings report, Organon hit all the milestones needed to move the stock out of its post-spin doldrums. Data given this quarter should alleviate bear concerns around leverage, revenue declines, growth strategy, dividend, and FCF. With P/E and P/FCF multiples at 5-6x, EV/...

Benjamin Graham is known for developing a fairly complex set of rules and formulas to determine a stock’s intrinsic value. In his final year, Graham offered a much simpler means of finding value, but these simple value comparison tools are often overlooked by many investors. ...

Organon & Co (OGN) Q2 2021 Earnings Conference Call August 12, 2021 8:30 AM ET Company Participants Jennifer Halchak – Vice President of Investor Relations Kevin Ali – Chief Executive Officer Matt Walsh – Chief Financial Officer Conference Call Participants Terence Fl...

The following slide deck was published by Organon & Co. in conjunction with their 2021 Q2 earnings call. For further details see: Organon & Co. 2021 Q2 - Results - Earnings Call Presentation

Second quarter 2021 revenue of $1,595 million Net income from continuing operations of $431 million, or $1.70 per diluted share; Adjusted net income from continuing operations of $437 million, or $1.72 per diluted share Adjusted EBITDA of $627 million Board of Directors de...

AZEK,AZUL,BIDU,BR,CELH,CSIQ,CYBR,EYE,GDRX,GRWG,IQ,KELYA,MDP,MIDD,MSGS,OGN,PLTR,SDGR,TAL,UTZ,ZNTL For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Thursday's open